FRESENIUS MEDICAL CARE AG (FME.DE) Stock Fundamental Analysis
Europe - FRA:FME - DE0005785802 - Common Stock
46.56 EUR
-0.13 (-0.28%)
FME gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 27 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of FME get a neutral evaluation. Nothing too spectacular is happening here. FME has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year FME was profitable.
FME had a positive operating cash flow in the past year.
FME had positive earnings in each of the past 5 years.
In the past 5 years FME always reported a positive cash flow from operatings.
1.2 Ratios
FME has a Return On Assets (2.10%) which is comparable to the rest of the industry.
FME's Return On Equity of 4.95% is in line compared to the rest of the industry. FME outperforms 40.74% of its industry peers.
FME has a Return On Invested Capital (3.84%) which is comparable to the rest of the industry.
FME had an Average Return On Invested Capital over the past 3 years of 3.14%. This is below the industry average of 5.99%.
The 3 year average ROIC (3.14%) for FME is below the current ROIC(3.84%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.1% | ||
| ROE | 4.95% | ||
| ROIC | 3.84% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
1.3 Margins
FME has a better Profit Margin (3.36%) than 66.67% of its industry peers.
In the last couple of years the Profit Margin of FME has declined.
Looking at the Operating Margin, with a value of 7.15%, FME is in line with its industry, outperforming 55.56% of the companies in the same industry.
FME's Operating Margin has declined in the last couple of years.
FME has a Gross Margin (24.67%) which is in line with its industry peers.
In the last couple of years the Gross Margin of FME has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.15% | ||
| PM (TTM) | 3.36% | ||
| GM | 24.67% |
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FME is destroying value.
The number of shares outstanding for FME remains at a similar level compared to 1 year ago.
Compared to 5 years ago, FME has less shares outstanding
Compared to 1 year ago, FME has an improved debt to assets ratio.
2.2 Solvency
FME has an Altman-Z score of 2.28. This is not the best score and indicates that FME is in the grey zone with still only limited risk for bankruptcy at the moment.
FME has a better Altman-Z score (2.28) than 70.37% of its industry peers.
FME has a debt to FCF ratio of 5.47. This is a neutral value as FME would need 5.47 years to pay back of all of its debts.
The Debt to FCF ratio of FME (5.47) is better than 77.78% of its industry peers.
A Debt/Equity ratio of 0.71 indicates that FME is somewhat dependend on debt financing.
FME has a Debt to Equity ratio of 0.71. This is in the better half of the industry: FME outperforms 70.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.47 | ||
| Altman-Z | 2.28 |
ROIC/WACC0.66
WACC5.85%
2.3 Liquidity
A Current Ratio of 1.44 indicates that FME should not have too much problems paying its short term obligations.
FME has a Current ratio of 1.44. This is in the better half of the industry: FME outperforms 74.07% of its industry peers.
FME has a Quick Ratio of 1.08. This is a normal value and indicates that FME is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of FME (1.08) is better than 70.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.08 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 17.17% over the past year.
The Earnings Per Share has been decreasing by -6.43% on average over the past years.
The Revenue has been growing slightly by 0.53% in the past year.
The Revenue has been growing slightly by 2.04% on average over the past years.
EPS 1Y (TTM)17.17%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%30%
Revenue 1Y (TTM)0.53%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%0.55%
3.2 Future
FME is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.25% yearly.
Based on estimates for the next years, FME will show a small growth in Revenue. The Revenue will grow by 3.89% on average per year.
EPS Next Y17.76%
EPS Next 2Y13.98%
EPS Next 3Y15.29%
EPS Next 5Y13.25%
Revenue Next Year1.28%
Revenue Next 2Y2.27%
Revenue Next 3Y3.09%
Revenue Next 5Y3.89%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 13.38 indicates a correct valuation of FME.
Compared to the rest of the industry, the Price/Earnings ratio of FME indicates a rather cheap valuation: FME is cheaper than 81.48% of the companies listed in the same industry.
FME is valuated cheaply when we compare the Price/Earnings ratio to 27.08, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 11.03, which indicates a very decent valuation of FME.
Based on the Price/Forward Earnings ratio, FME is valued cheaply inside the industry as 81.48% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.09, FME is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.38 | ||
| Fwd PE | 11.03 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FME indicates a slightly more expensive valuation: FME is more expensive than 74.07% of the companies listed in the same industry.
FME's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.56 | ||
| EV/EBITDA | 11.88 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
FME's earnings are expected to grow with 15.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.75
PEG (5Y)N/A
EPS Next 2Y13.98%
EPS Next 3Y15.29%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.10%, FME has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.53, FME pays a better dividend. On top of this FME pays more dividend than 88.89% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.30, FME pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.1% |
5.2 History
The dividend of FME has a limited annual growth rate of 0.31%.
Dividend Growth(5Y)0.31%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
64.37% of the earnings are spent on dividend by FME. This is not a sustainable payout ratio.
FME's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP64.37%
EPS Next 2Y13.98%
EPS Next 3Y15.29%
FRA:FME (10/28/2025, 3:05:01 PM)
46.56
-0.13 (-0.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners43.16%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap27.32B
Revenue(TTM)19.52B
Net Income(TTM)656.42M
Analysts67.2
Price Target50.35 (8.14%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.1% |
Yearly Dividend1.19
Dividend Growth(5Y)0.31%
DP64.37%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.03%
Min EPS beat(2)14.89%
Max EPS beat(2)27.17%
EPS beat(4)4
Avg EPS beat(4)20.72%
Min EPS beat(4)14.89%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)15.78%
EPS beat(12)10
Avg EPS beat(12)13.92%
EPS beat(16)12
Avg EPS beat(16)10.11%
Revenue beat(2)1
Avg Revenue beat(2)-0.3%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)2.74%
Revenue beat(4)2
Avg Revenue beat(4)0.26%
Min Revenue beat(4)-4.4%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.45%
Revenue beat(12)5
Avg Revenue beat(12)-0.49%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)-0.4%
PT rev (3m)-2.24%
EPS NQ rev (1m)-0.75%
EPS NQ rev (3m)0.43%
EPS NY rev (1m)0%
EPS NY rev (3m)3.28%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-1.22%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-0.88%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.38 | ||
| Fwd PE | 11.03 | ||
| P/S | 1.4 | ||
| P/FCF | 13.56 | ||
| P/OCF | 9.92 | ||
| P/B | 2.06 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.88 |
EPS(TTM)3.48
EY7.47%
EPS(NY)4.22
Fwd EY9.07%
FCF(TTM)3.43
FCFY7.38%
OCF(TTM)4.69
OCFY10.08%
SpS33.26
BVpS22.61
TBVpS-2.73
PEG (NY)0.75
PEG (5Y)N/A
Graham Number42.08
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.1% | ||
| ROE | 4.95% | ||
| ROCE | 5.44% | ||
| ROIC | 3.84% | ||
| ROICexc | 4.19% | ||
| ROICexgc | 11.45% | ||
| OM | 7.15% | ||
| PM (TTM) | 3.36% | ||
| GM | 24.67% | ||
| FCFM | 10.32% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score6
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.47 | ||
| Debt/EBITDA | 3.14 | ||
| Cap/Depr | 45.83% | ||
| Cap/Sales | 3.79% | ||
| Interest Coverage | 3.82 | ||
| Cash Conversion | 91.56% | ||
| Profit Quality | 307% | ||
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.08 | ||
| Altman-Z | 2.28 |
F-Score6
WACC5.85%
ROIC/WACC0.66
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)17.17%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%30%
EPS Next Y17.76%
EPS Next 2Y13.98%
EPS Next 3Y15.29%
EPS Next 5Y13.25%
Revenue 1Y (TTM)0.53%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%0.55%
Revenue Next Year1.28%
Revenue Next 2Y2.27%
Revenue Next 3Y3.09%
Revenue Next 5Y3.89%
EBIT growth 1Y2.71%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.66%
EBIT Next 3Y30.5%
EBIT Next 5Y19.14%
FCF growth 1Y14.07%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y14.41%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%
FRESENIUS MEDICAL CARE AG / FME.DE FAQ
What is the fundamental rating for FME stock?
ChartMill assigns a fundamental rating of 5 / 10 to FME.DE.
What is the valuation status of FRESENIUS MEDICAL CARE AG (FME.DE) stock?
ChartMill assigns a valuation rating of 6 / 10 to FRESENIUS MEDICAL CARE AG (FME.DE). This can be considered as Fairly Valued.
What is the profitability of FME stock?
FRESENIUS MEDICAL CARE AG (FME.DE) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for FME stock?
The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE AG (FME.DE) is 13.38 and the Price/Book (PB) ratio is 2.06.
Can you provide the dividend sustainability for FME stock?
The dividend rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 6 / 10 and the dividend payout ratio is 64.37%.